1. 国自然重大项目培育计划（国家级  No92046015）

2. 北京市科委-教委联合资助项目1项（省部级  编号KZ202010025047）

3. 首都医科大学基础-临床科研合作基金1项（局级  基金项目编号15JL33）

4. 首都医科大学附属北京友谊医院启动基金1项（基金项目编号yyqdkt2014-12）

1.GuoX, Li W, Hu J, Zhu EC, SuQ. Hepatotoxicity in patients withsolid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitorsplus chemotherapy, or chemotherapy alone: systematic review and meta-analysis.Eur J Clin Pharmacol.2020, 6. Doi: 10.1007/s00228-020-02903-2.(IF：3.04 通讯作者)

2.SuQ ; ZhuEC; Wu JB; Li T; Hou YL ; Wang DY ; Gao ZH ,Risk of pneumonitis and pneumoniaassociated with immune checkpoint inhibitors forsolid tumors: a systematic review andmeta-analysis, Frontiers in Immunology, 2019.2.4, 10(108): 1~15（IF 5.511 独立一作）

3.WangDY, Cloutier G, Fan Y, Hou YL, Su Z, Su Q, Wan MX. Automatic Respiratory GatingHepatic DCEUS-based Dual-phase Multi-parametric Functional Perfusion Imagingusing a Derivative Principal Component Analysis. Theranostics 2019 9(21): 6143-6156. (IF 8.063共同通讯)

4.WangDY ; Xu SS; Zhang KJ; Zhang XY; Yang X; Xiao MN; Wan MX, Su Q. A fast scheme for renal microvascularperfusion functional imaging:Assessed by an imaging quality evaluationmodel, Medical Physics, 2019.2.10, 46(2):738~745（IF 2.884 共同通讯）

5.SuQ ; ZhuEC; Qu YL; Wang DY; Qu WW; Zhang CG; Wu T; Gao ZH ,Serum level of co-expressedhub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductaladenocarcinoma, Journal of cancer, 2018.10.11, 9(21):3991~3999(IF 3.249 独立一作)

6.SuQ; Sun ZG; Zhang CG; Hou YL ; CaoBW.PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy inadvanced NSCLC patients , after first-line treatment option: systemsassessment. Oncotarget 2017.8.29: 59677-596898 (35) (IF5.100 独立一作)

7.SuQ; Zhang X; Shen X; Hou Y; Sun Z;Gao ZH. Risk of immune-related colitis with PD-1/PD-L1 inhibitors vschemotherapy in solid tumors: systems assessment. Journal of Cancer 2018 (9):1614-1622. (IF 3.249 独立一作)

8.SuQ; Zhang XC; Wang DY; Zhang HR; ZhuC; Hou YL ; Liu JL ; Gao ZH. The risk of immune-related endocrine disordersassociated with anti-PD-1 , inhibitors therapy for solid tumors: A systematicreview and meta-analysis. International immunopharmacology 2018 59(59):328-338.(IF 3.118独立一作)

9.SuQ; Zhang XC; Zhang CG; Hou YL; YaoYX; Cao BW. Risk of Immune-Related Pancreatitis in Patients with Solid TumorsTreated with Immune , Checkpoint Inhibitors: Systematic Assessment withMeta-Analysis. J Immunol Res 2018 3:1027323.(IF 3.298 独立一作)

10.XuM,  Nie Y, Yang Y,  Lu YT,  Su Q; Risk of Neurological ToxicitiesFollowing the Use of Different Immune Checkpoint Inhibitor Regimens in SolidTumors A Systematic Review and Meta-analysis. Neurologist 2019 24(3): 76-83 (IF0.722 独立通讯)

11.WangD, Zhang X, Sang Y, Qu Z, SuQ, Zhao J, Wan M.Influence of guided waves in bone onpulse-inversion contrast-enhanced ultrasound. Med Phys. 2019 30:1-8(IF 2.884 共同通讯)

12. 2019年 副主编出版《肿瘤科疾病病例精解》